This study aims to identify genetic causes of adverse events after cardiac surgery, such as atrial fibrillation, myocardial infarction, renal dysfunction and heart failure. Patients undergoing heart surgery at Brigham and Women's Hospital and Texas Heart Institute are eligible to participate.
This study aims to identify genetic causes of adverse events after cardiac surgery, such as atrial fibrillation, myocardial infarction, renal dysfunction and heart failure. In addition, we also examine blood and urine biomarkers (proteins).
Study Type
OBSERVATIONAL
Enrollment
4,000
Brigham and Women's Hospital
Boston, Massachusetts, United States
COMPLETEDUT Southwestern Medical Center
Dallas, Texas, United States
RECRUITINGDepartment Texas Heart Institute at St. Luke's Episcopal Hospital
Houston, Texas, United States
COMPLETEDMortality (i.e. number of participants who are deceased during postoperative day 0 up to year 5)
Data will be collected from electronic medical records; data points to be collected for this measurement include serum creatinine.
Time frame: Day of procedure to year 5
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.